The Simply Good Foods Company (SMPL) 10-Q 8 Apr 21 2021 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Feb. 27, 2021	Apr. 05, 2021
Document Information [Line Items]
Entity Central Index Key	0001702744
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Feb. 27, 2021
Entity Registrant Name	The Simply Good Foods Company
Document Fiscal Period Focus	Q2
Entity File Number	001-38115
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-1038121
Entity Address, Address Line One	1225 17th Street, Suite 1000
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	303
Local Phone Number	633-2840
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	SMPL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Current Fiscal Year End Date	--08-28
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		95,762,832
Document Transition Report	false
Amendment Flag	false
Document Fiscal Year Focus	2021

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Feb. 27, 2021	Aug. 29, 2020
Current assets:
Cash and cash equivalents	$ 91,307	$ 95,847
Accounts receivable, net	97,329	89,740
Inventories	82,771	59,085
Prepaid expenses	4,894	3,644
Other current assets	12,833	11,947
Total current assets	289,134	260,263
Long-term assets:
Property and equipment, net	11,092	11,850
Intangible assets, net	1,146,039	1,158,768
Goodwill	543,134	544,774
Other long-term assets	32,119	32,790
Total assets	2,021,518	2,008,445
Current liabilities:
Accounts payable	43,585	32,240
Accrued interest	384	960
Accrued expenses and other current liabilities	36,313	38,007
Current maturities of long-term debt	278	271
Total current liabilities	80,560	71,478
Long-term liabilities:
Long-term debt, less current maturities	548,884	596,879
Deferred income taxes	92,536	84,352
Other long-term liabilities	20,880	22,765
Total liabilities	742,860	775,474
See commitments and contingencies (Note 10)
Stockholders’ equity:
Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued	0	0
Common stock, $0.01 par value, 600,000,000 shares authorized, 95,856,715 and 95,751,845 shares issued at February 27, 2021 and August 29, 2020, respectively	959	958
Treasury stock, 98,234 and 98,234 shares at cost at February 27, 2021 and August 29, 2020, respectively	(2,145)	(2,145)
Additional paid-in-capital	1,098,375	1,094,507
Retained earnings	182,150	140,530
Accumulated other comprehensive loss	(681)	(879)
Total stockholders’ equity	1,278,658	1,232,971
Total liabilities and stockholders’ equity	$ 2,021,518	$ 2,008,445

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Feb. 27, 2021	Aug. 29, 2020
Statement of Financial Position [Abstract]
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock shares authorized (in shares)	100,000,000	100,000,000
Preferred stock shares issued (in shares)	0	0
Common stock par value (in dollars per share)	$ 0.01	$ 0.01
Common stock shares authorized (in shares)	600,000,000	600,000,000
Common stock shares issued (in shares)	95,856,715	95,751,845
Treasury stock (in shares)	98,234	98,234

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Income Statement [Abstract]
Net sales	$ 230,607	$ 227,101	$ 461,759	$ 379,254
Cost of goods sold	140,342	141,707	277,453	231,654
Gross profit	90,265	85,394	184,306	147,600
Operating expenses:
Selling and marketing	26,150	27,041	51,345	45,475
General and administrative	26,562	28,103	51,977	46,248
Depreciation and amortization	4,212	4,287	8,456	6,740
Business transaction costs	0	694	0	26,853
Total operating expenses	56,924	60,125	111,778	125,316
Income from operations	33,341	25,269	72,528	22,284
Other income (expense):
Interest income	0	85	3	1,464
Interest expense	(7,995)	(10,589)	(16,367)	(15,558)
Gain (loss) on foreign currency transactions	975	(194)	984	(178)
Other income	112	8	159	45
Total other expense	(6,908)	(10,690)	(15,221)	(14,227)
Income before income taxes	26,433	14,579	57,307	8,057
Income tax expense	7,313	3,922	15,687	2,193
Net income	19,120	10,657	41,620	5,864
Other comprehensive income:
Foreign currency translation adjustments	243	(141)	198	(141)
Comprehensive income	$ 19,363	$ 10,516	$ 41,818	$ 5,723
Earnings per share from net income:
Basic (in dollars per share)	$ 0.20	$ 0.11	$ 0.43	$ 0.06
Diluted (in dollars per share)	$ 0.19	$ 0.11	$ 0.41	$ 0.06
Weighted average shares outstanding:
Basic (in shares)	95,734,591	95,339,489	95,712,057	92,524,061
Diluted (in shares)	101,152,896	100,336,571	100,604,137	97,597,614

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020
Operating activities
Net income	$ 41,620	$ 5,864
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	9,021	7,119
Amortization of deferred financing costs and debt discount	2,108	1,569
Stock compensation expense	3,594	3,795
Unrealized loss (gain) on foreign currency transactions	(985)	178
Deferred income taxes	8,119	2,485
Amortization of operating lease right-of-use asset	2,253	1,652
Loss on operating lease right-of-use asset impairment	681	0
(Gain) loss on Termination of Lease	(154)	0
Other operating activities	216	789
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable, net	(7,015)	(19,062)
Inventories	(24,502)	768
Prepaid expenses	(1,191)	(873)
Other current assets	(674)	(5,808)
Accounts payable	10,275	(2,953)
Accrued interest	(577)	175
Accrued expenses and other current liabilities	(1,881)	(8,760)
Other assets and liabilities	(1,144)	(1,824)
Net cash provided by (used in) operating activities	39,764	(14,886)
Investing activities
Purchases of property and equipment	(449)	(481)
Issuance of notes receivable	0	(1,250)
Acquisition of business, net of cash acquired	0	(984,201)
Proceeds from sale of business	5,800	0
Investments in intangible assets	(114)	0
Net cash provided by (used in) investing activities	5,237	(985,932)
Financing activities
Proceeds from option exercises	527	931
Issuance of common stock	(252)	(80)
Payments of finance lease obligations	(168)	(157)
Deferred financing costs	0	(8,208)
Principal payments of long-term debt	(50,000)	(21,000)
Proceeds from Issuance of Common Stock	0	352,542
Equity issuance costs	0	(3,323)
Proceeds from Issuance of Long-term Debt	0	460,000
Net cash (used in) provided by financing activities	(49,893)	780,705
Net decrease in cash	(4,892)	(220,113)
Cash and cash equivalents
Effect of exchange rate on cash	352	(113)
Cash at beginning of period	95,847	266,341
Cash and cash equivalents at end of period	91,307	46,115
Supplemental disclosures of cash flow information
Cash paid for interest	14,835	13,814
Cash paid for taxes	10,023	4,345
Non-cash proceeds from sale of business	3,000	0
Operating lease right-of-use assets recognized at ASU 2016-02 transition	0	5,102
Finance lease right-of-use assets recognized at ASU 2016-02 transition	0	1,185
Operating lease right-of-use assets recognized after ASU 2016-02 transition	$ 316	$ 2,733

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders Equity Statement - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance at Aug. 31, 2019	$ 837,444	$ 820	$ (2,145)	$ 733,775	$ 105,830	$ (836)
Beginning balance (in shares) at Aug. 31, 2019		81,973,284
Beginning balance, Treasury (in shares) at Aug. 31, 2019			98,234
Net income	(4,793)				(4,793)
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	1,673			1,673
Public equity offering (in shares)		13,379,205
Public equity offering	349,219	$ 134		349,085
Shares issued upon vesting of Restricted Stock Units	(70)	$ 0		(70)
Shares issued upon vesting of Restricted Stock Units (in shares)		46,911
Exercise of options to purchase common stock	208	$ 0		208
Exercise of options to purchase common stock (in shares)		17,372
Ending balance (in shares) at Nov. 30, 2019		95,416,772
Ending balance, Treasury (in shares) at Nov. 30, 2019			98,234
Ending balance at Nov. 30, 2019	1,183,681	$ 954	$ (2,145)	1,084,671	101,037	(836)
Beginning balance at Aug. 31, 2019	837,444	$ 820	$ (2,145)	733,775	105,830	(836)
Beginning balance (in shares) at Aug. 31, 2019		81,973,284
Beginning balance, Treasury (in shares) at Aug. 31, 2019			98,234
Net income	5,864
Foreign currency translation adjustments	(141)
Ending balance (in shares) at Feb. 29, 2020		95,476,537
Ending balance, Treasury (in shares) at Feb. 29, 2020			98,234
Ending balance at Feb. 29, 2020	1,197,033	$ 955	$ (2,145)	1,087,506	111,694	(977)
Beginning balance at Nov. 30, 2019	1,183,681	$ 954	$ (2,145)	1,084,671	101,037	(836)
Beginning balance (in shares) at Nov. 30, 2019		95,416,772
Beginning balance, Treasury (in shares) at Nov. 30, 2019			98,234
Net income	10,657				10,657
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	2,122			2,122
Foreign currency translation adjustments	(141)					(141)
Shares issued upon vesting of Restricted Stock Units	(10)	$ 0		(10)
Shares issued upon vesting of Restricted Stock Units (in shares)		771
Exercise of options to purchase common stock	724	$ 1		723
Exercise of options to purchase common stock (in shares)		58,994
Ending balance (in shares) at Feb. 29, 2020		95,476,537
Ending balance, Treasury (in shares) at Feb. 29, 2020			98,234
Ending balance at Feb. 29, 2020	1,197,033	$ 955	$ (2,145)	1,087,506	111,694	(977)
Beginning balance at Aug. 29, 2020	$ 1,232,971	$ 958	$ (2,145)	1,094,507	140,530	(879)
Beginning balance (in shares) at Aug. 29, 2020		95,751,845
Beginning balance, Treasury (in shares) at Aug. 29, 2020	98,234		98,234
Net income	$ 22,500				22,500
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	1,110			1,110
Foreign currency translation adjustments	(45)					(45)
Shares issued upon vesting of Restricted Stock Units	(201)	$ 0		(201)
Shares issued upon vesting of Restricted Stock Units (in shares)		53,908
Exercise of options to purchase common stock	157	$ 0		157
Exercise of options to purchase common stock (in shares)		13,118
Ending balance (in shares) at Nov. 28, 2020		95,818,871
Ending balance, Treasury (in shares) at Nov. 28, 2020			98,234
Ending balance at Nov. 28, 2020	1,256,492	$ 958	$ (2,145)	1,095,573	163,030	(924)
Beginning balance at Aug. 29, 2020	$ 1,232,971	$ 958	$ (2,145)	1,094,507	140,530	(879)
Beginning balance (in shares) at Aug. 29, 2020		95,751,845
Beginning balance, Treasury (in shares) at Aug. 29, 2020	98,234		98,234
Net income	$ 41,620
Foreign currency translation adjustments	$ 198
Ending balance (in shares) at Feb. 27, 2021		95,856,715
Ending balance, Treasury (in shares) at Feb. 27, 2021	98,234		98,234
Ending balance at Feb. 27, 2021	$ 1,278,658	$ 959	$ (2,145)	1,098,375	182,150	(681)
Beginning balance at Nov. 28, 2020	1,256,492	$ 958	$ (2,145)	1,095,573	163,030	(924)
Beginning balance (in shares) at Nov. 28, 2020		95,818,871
Beginning balance, Treasury (in shares) at Nov. 28, 2020			98,234
Net income	19,120				19,120
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	2,484			2,484
Foreign currency translation adjustments	243					243
Shares issued upon vesting of Restricted Stock Units	(51)	$ 0		(51)
Shares issued upon vesting of Restricted Stock Units (in shares)		7,034
Exercise of options to purchase common stock	$ 370	$ 1		369
Exercise of options to purchase common stock (in shares)		30,810
Ending balance (in shares) at Feb. 27, 2021		95,856,715
Ending balance, Treasury (in shares) at Feb. 27, 2021	98,234		98,234
Ending balance at Feb. 27, 2021	$ 1,278,658	$ 959	$ (2,145)	$ 1,098,375	$ 182,150	$ (681)

Nature of Operations and Princi

Nature of Operations and Principles of Consolidation	6 Months Ended
	Feb. 27, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Principles of Consolidation	Description of Business The Simply Good Foods Company (“Simply Good Foods” or the "Company") is a consumer-packaged food and beverage company that aims to lead the nutritious snacking movement with trusted brands that offer a variety of convenient, innovative, great-tasting, better-for-you snacks and meal replacements. The Company’s nutritious snacking platform consists of the following core brands that specialize in providing products for consumers that follow certain nutritional philosophies, dietary approaches and/or health-and-wellness trends: Atkins® for those following a low-carb lifestyle; and Quest® for consumers seeking to partner with a brand that makes the foods they crave work for them, not against them, through a variety of protein-rich foods and beverages that also limit sugars and simple carbs. The Company distributes its products in major retail channels, primarily in North America, including grocery, club and mass merchandise, as well as through e-commerce, convenience, specialty and other channels. The Company's portfolio of nutritious snacking brands gives it a strong platform with which to introduce new products, expand distribution, and attract new consumers to its products. The Company's platform also positions it to continue to selectively pursue acquisition opportunities of brands in the nutritious snacking category. The common stock of Simply Good Foods is listed on the Nasdaq Capital Market under the symbol “SMPL.” Unaudited Interim Condensed Consolidated Financial Statements The unaudited interim condensed consolidated financial statements include the accounts of Simply Good Foods and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated. Unless the context otherwise requires, “we,” “us,” “our” and the “Company” refer to Simply Good Foods and its subsidiaries. The Company maintains its accounting records on a 52/53-week fiscal year, ending on the last Saturday in August of each year. The interim condensed consolidated financial statements and related notes of the Company and its subsidiaries are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The unaudited interim condensed consolidated financial statements reflect all adjustments and disclosures which are, in the Company's opinion, necessary for a fair presentation of the results of operations, financial position and cash flows for the indicated periods. All such adjustments were of a normal and recurring nature unless otherwise disclosed. The year-end balance sheet data was derived from the audited financial statements and, in accordance with the instructions to Form 10-Q, certain information and footnote disclosures required by GAAP have been condensed or omitted. The results reported in these unaudited interim condensed consolidated financial statements are not necessarily indicative of the results that may be reported for the entire fiscal year and should be read in conjunction with the Company's consolidated financial statements for the fiscal year ended August 29, 2020, included in our Annual Report on Form 10-K (“Annual Report”), filed with the SEC on October 28, 2020. The Company remains uncertain of the ultimate effect COVID-19 could have on its business notwithstanding the distribution of several U.S. government approved vaccines and various federal, state and local governments having begun to ease the movement restrictions and public health initiatives while continuing to adhere to enhanced safety measures, such as physical distancing and face mask protocols. This uncertainty as to the duration and severity of economic effects from the COVID-19 pandemic stems from the potential for, among other things, (i) continued rates of reported cases of COVID-19 and the potential for mutations of COVID-19 to result in increased rates of reported cases for which currently approved vaccines are not effective, (ii) unexpected supply chain disruptions, (iii) changes to customer operations, (iv) continued or additional changes in consumer purchasing and consumption behavior beyond those evidenced to date, and (v) the closure of customer establishments.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Feb. 27, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Refer to Note 3, Summary of Significant Accounting Policies , to the consolidated financial statements included in the Company's Annual Report for a description of significant accounting policies. Recently Issued and Adopted Accounting Pronouncements Recently Issued Accounting Pronouncements Not Yet Adopted In December 2019, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which amends the existing guidance relating to the accounting for income taxes. This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of U.S. GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not expect that the adoption of this ASU will be material to its consolidated financial statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. The amendments in this ASU are effective for all entities and can be applied to contract modifications due to rate reform and eligible existing and new hedging relationships entered into between March 12, 2020 through December 31, 2022. The amendments of this ASU should be applied on a prospective basis. The Company will continue to monitor the effects of rate reform, if any, on its contracts and the effects of adoption of this ASU through December 31, 2022. The Company does not anticipate the amendments in this ASU to be material to its consolidated financial statements. In October 2020, the FASB issued ASU No. 2020-10, Codification Improvements, which provides updates for technical corrections, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements across various areas of accounting within U.S. GAAP. This ASU is effective for all entities for fiscal years beginning after December 15, 2020, with early adoption permitted. The amendments of this ASU should be applied retrospectively. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not anticipate the adoption of this ASU will be material to its consolidated financial statements. Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326), which modified the measurement of expected credit losses of certain financial instruments. The Company adopted this ASU as of the first day of fiscal 2021. As a result of adopting this ASU, the Company changed its method of estimating its allowance for doubtful accounts for trade receivables to be based upon the Company's historical credit loss experience adjusted for asset-specific risk characteristics, current economic conditions, and reasonable forecasts. The change in estimating the allowance for doubtful accounts did not have a material effect on the Company's consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modified disclosure requirements on fair value measurements of Accounting Standards Codification (“ASC”) 820. The Company adopted this ASU as of the first day of fiscal 2021. The adoption of this ASU did not have a material effect on the consolidated financial statements or the related disclosures.

Business Combination (Notes)

Business Combination (Notes)	3 Months Ended
	Feb. 27, 2021
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	On August 21, 2019, the Company's wholly-owned subsidiary Simply Good Foods USA, Inc., formerly known as Atkins Nutritionals, Inc., (“Simply Good USA”) entered into a Stock and Unit Purchase Agreement (the "Purchase Agreement") to acquire Quest Nutrition, LLC ("Quest"), a healthy lifestyle food company (the "Acquisition of Quest"). On November 7, 2019, Simply Good USA completed the Acquisition of Quest, via Simply Good USA’s direct or indirect acquisition of 100% of the equity interests of Voyage Holdings, LLC and VMG Quest Blocker, Inc. (the “Target Companies”) for a cash purchase price at closing of $988.9 million subject to customary post-closing adjustments for the Target Companies’ levels of cash, indebtedness, net working capital and transaction expenses as of the closing date. Simply Good USA acquired Quest as a part of the Company's vision to lead the nutritious snacking movement with trusted brands that offer a variety of convenient, innovative, great-tasting, better-for-you snacks and meal replacements. Quest is a healthy lifestyle food company offering a variety of bars, cookies, chips, ready-to-drink shakes and pizzas that compete in many of the attractive, fast growing sub-segments within the nutritional snacking category. The Acquisition of Quest was funded by the Company through a combination of cash, equity and debt financing. Total consideration paid on the closing date was $988.9 million. Cash sources of funding included $195.3 million of cash on hand, net proceeds of approximately $350.0 million from an underwritten public offering of common stock, and $443.6 million in new term loan debt. In the third fiscal quarter of 2020, the Company received a post-closing release from escrow of approximately $2.1 million related to net working capital adjustments, resulting in a total net consideration paid of $986.8 million as of February 27, 2021. For the twenty-six weeks ended February 29, 2020, Business transaction costs within the Consolidated Statements of Operations and Comprehensive Income were $26.9 million, which included $14.5 million of transaction advisory fees related to the Acquisition of Quest, $3.2 million of banker commitment fees, $6.1 million of non-deferrable debt issuance costs related to the incremental term loan, and $3.1 million of other costs, including legal, due diligence, and accounting fees. Included in the transaction advisory fees was $12.0 million paid to Centerview Partners LLC, an investment banking firm that served as the lead financial advisor to the Company for this transaction. Three members of the Company’s Board of Directors, Messrs. Kilts, West, and Ratzan, have business relationships with certain partners of Centerview Partners LLC (including relating to Centerview Capital Consumer, a private equity firm and affiliate of Conyers Park Sponsor LLC), but they are not themselves partners, executives or employees of Centerview Partners LLC, and Centerview Partners LLC is not a related party of the Company pursuant to applicable rules and policies. The advisory fee paid to Centerview Partners LLC represented approximately 1.2% of the total cash purchase price paid by the Company on the closing date of the Acquisition of Quest. All transaction advisory fees relating to the Acquisition of Quest were approved by the Company’s Audit Committee. The following table sets forth the final purchase price allocation of the Acquisition of Quest to the estimated fair value of the net assets acquired at the date of acquisition, in thousands: Assets acquired: Cash and cash equivalents $ 4,745 Accounts receivable, net 25,359 Inventories 44,032 Prepaid assets 1,214 Other current assets 3,812 Property and equipment, net (1) 9,843 Intangible assets, net (2) 868,375 Other long-term assets 20,997 Liabilities assumed: Accounts payable 25,200 Other current liabilities 11,237 Deferred income taxes (3) 10,754 Other long-term liabilities 18,891 Total identifiable net assets 912,295 Goodwill (4) 74,525 Total assets acquired and liabilities assumed $ 986,820 (1) Property and equipment, net primarily consisted of leasehold improvements for the Quest headquarters of $6.9 million, furniture and fixtures of $2.2 million, and equipment of $0.7 million. The Quest headquarters lease ends in April 2029. The useful lives of the leasehold improvements, furniture and fixtures, and equipment are consistent with the Company's accounting policies. (2) Intangible assets were recorded at fair value consistent with ASC 820 as a result of the Acquisition of Quest. Intangible assets consisted of $750.0 million of indefinite brands and trademarks, $115.0 million of amortizable customer relationships, and $3.4 million of internally developed software. The useful lives of the intangible assets are disclosed in Note 5 of the consolidated financial statements. The fair value measurement of the assets and liabilities was based on significant inputs not observable in the market and thus represent Level 3 measurements within the fair value measurement hierarchy. Level 3 fair market values were determined using a variety of information, including estimated future cash flows and market comparable data and companies. The fair values of the intangible assets were estimated using inputs primarily from the income approach and the with/without method, which estimates the value using the cash flow impact in a hypothetical scenario where the customer relationships are not in place. The significant assumptions used in estimating the fair value of the intangible assets include the estimated life the asset will contribute to cash flows, profitability, and the estimated discount rate. (3) Primarily as a result of the fair value attributable to the identifiable intangible assets, the deferred income tax liability was $10.8 million. (4) Goodwill was recorded at fair value consistent with ASC 820 as a result of the Acquisition of Quest. Amounts recorded for goodwill created in an acquisition structured as a stock purchase for tax are generally not expected to be deductible for tax purposes. Amounts recorded for goodwill resulting in a tax basis step-up are generally expected to be deductible for tax purposes. Tax deductible Goodwill was estimated to be $67.7 million. Goodwill represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The Company completed its final assessment of purchase price allocation for the Acquisition of Quest to the estimated fair value of the net assets acquired at the date of acquisition during the first quarter of fiscal 2021. Since the initial preliminary estimates reported in the first fiscal quarter of 2020, the Company updated certain amounts reflected in the final purchase price allocation, as summarized in the fair values of assets acquired and liabilities assumed as set forth above. Specifically, the carrying amount of the intangible assets, net were increased by $20.0 million as a result of valuation adjustments related to the Company's finalization of tax attributes, which also resulted in a decrease to deferred income taxes of $3.2 million. Additionally, accounts receivable, net decreased $4.3 million and inventories increased $0.9 million due to fair value measurement period adjustments, and the carrying amount of property and equipment, net decreased by $0.5 million to reflect its estimated fair value. As a result of these adjustments and the change in total net consideration paid of approximately $2.1 million related to net working capital adjustments discussed above, goodwill decreased $21.5 million. Measurement period adjustments were recognized in the reporting period in which the adjustments were determined and calculated as if the accounting had been completed at the acquisition date. The results of Quest's operations have been included in the Company's Consolidated Financial Statements since November 7, 2019, the date of acquisition. The following table provides net sales from the acquired Quest business included in the Company's results: Thirteen Weeks Ended Twenty-Six Weeks Ended (in thousands) February 27, 2021 February 29, 2020 February 27, 2021 February 29, 2020 Net sales (1) $ 105,025 $ 88,305 $ 200,794 $ 105,387 (1) Net sales for the thirteen and twenty-six weeks ended February 27, 2021 excludes immaterial international net sales. Unaudited Pro Forma Financial Information Pro forma financial information is not intended to represent or be indicative of the actual results of operations of the combined business that would have been reported had the Acquisition of Quest been completed at the beginning of the fiscal year 2019, nor is it representative of future operating results of the Company. The following unaudited pro forma financial information presents the combined results of the Company and Quest as if the Acquisition of Quest has occurred at the beginning of fiscal 2019: Thirteen Weeks Ended Twenty-Six Weeks Ended (in thousands) February 29, 2020 February 29, 2020 Revenue $ 227,101 $ 447,657 Gross profit $ 90,479 $ 178,667 Net income $ 15,049 $ 30,697

Revenue Recognition

Revenue Recognition	3 Months Ended
	Feb. 27, 2021
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Text Block]	Revenues from transactions with external customers for each of the Company’s products would be impracticable to disclose and management does not view its business by product line. The following is a summary of revenue disaggregated by geographic area and core brands: Thirteen Weeks Ended Twenty-Six Weeks Ended (In thousands) February 27, 2021 February 29, 2020 February 27, 2021 February 29, 2020 North America Atkins $ 114,155 $ 131,435 $ 236,916 $ 259,247 Quest (2) 105,025 88,305 200,794 105,387 Total North America (1) 219,180 219,740 437,710 364,634 International 11,427 7,361 24,049 14,620 Total net sales $ 230,607 $ 227,101 $ 461,759 $ 379,254 (1) Revenue within the North America geographic area substantially relates to the United States and includes the divested SimplyProtein brand. (2) Quest net sales are primarily in North America.

Goodwill and Intangibles

Goodwill and Intangibles	6 Months Ended
	Feb. 27, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangibles	Changes to Goodwill during the thirteen week period ended February 27, 2021 were as follows: (in thousands) Goodwill Balance as of August 29, 2020 $ 544,774 Acquisition of business, measurement period adjustment 1,178 Sale of business (2,818) Balance as of February 27, 2021 $ 543,134 The change in Goodwill attributed to the acquisition of a business during the twenty-six weeks ended February 27, 2021 was the result of measurement period adjustments made to finalize the acquisition method of accounting for the Acquisition of Quest as described in Note 3. Additionally, effective September 24, 2020, the Company sold the assets exclusively related to its SimplyProtein® brand of products for approximately $8.8 million of consideration, including cash of $5.8 million and a note receivable for $3.0 million, to a newly formed entity led by the Company’s former Canadian-based management team who had been responsible for this brand prior to the sale transaction (the "SimplyProtein Sale"). In addition to purchasing these assets, the buyer assumed certain liabilities related to the SimplyProtein brand’s business. There was no gain or loss recognized as a result of the SimplyProtein Sale. In conjunction with the SimplyProtein Sale, the Company disposed of $2.8 million of goodwill associated with the SimplyProtein business. There were no impairment charges related to goodwill during the thirteen and twenty-six weeks ended February 27, 2021 or since the inception of the Company. Intangible assets, net in the Consolidated Balance Sheets consist of the following: February 27, 2021 (In thousands) Useful life Gross carrying amount Accumulated amortization Net carrying amount Intangible assets with indefinite life: Brands and trademarks Indefinite life $ 974,000 $ — $ 974,000 Intangible assets with finite lives: Customer relationships 15 years 174,000 24,303 149,697 Proprietary recipes and formulas 7 years 7,000 3,631 3,369 Licensing agreements 14 years 22,000 5,706 16,294 Software and website development costs 3 - 5 years 5,302 2,678 2,624 Intangible assets in progress 3 - 5 years 55 — 55 $ 1,182,357 $ 36,318 $ 1,146,039 August 29, 2020 (In thousands) Useful life Gross carrying amount Accumulated amortization Net carrying amount Intangible assets with indefinite life: Brands and trademarks Indefinite life $ 979,000 $ — $ 979,000 Intangible assets with finite lives: Customer relationships 15 years 174,000 18,503 155,497 Proprietary recipes and formulas 7 years 7,000 3,131 3,869 Licensing agreements 14 years 22,000 4,920 17,080 Software and website development costs 3 - 5 years 5,967 2,645 3,322 $ 1,187,967 $ 29,199 $ 1,158,768 Changes in Intangible assets, net during the twenty-six weeks ended February 27, 2021 were primarily related to the SimplyProtein Sale and recurring amortization expense. In conjunction with the SimplyProtein Sale, the Company sold its SimplyProtein brand intangible asset, which had a carrying value of approximately $5.0 million as of the date of the sale. Amortization expense related to intangible assets during each of the thirteen weeks ended February 27, 2021 and February 29, 2020 was $3.9 million, respectively. Amortization expense related to intangible assets during the twenty-six weeks ended February 27, 2021 and February 29, 2020 was $7.7 million and $6.2 million, respectively. There were no impairment charges related to intangible assets during the thirteen and twenty-six weeks ended February 27, 2021 and February 29, 2020. Estimated future amortization for each of the next five fiscal years and thereafter is as follows: (In thousands) Amortization Remainder of 2021 $ 7,674 2022 15,224 2023 14,938 2024 14,257 2025 13,171 2026 and thereafter 106,720 Total $ 171,984

Long-Term Debt and Line of Cred

Long-Term Debt and Line of Credit	6 Months Ended
	Feb. 27, 2021
Debt Disclosure [Abstract]
Debt Disclosure	On July 7, 2017, the Company entered into a credit agreement with Barclays Bank PLC and other parties (as amended to date, the “Credit Agreement”). The Credit Agreement provides for (i) a term facility of $200.0 million (“Term Facility”) with a seven five On March 16, 2018 (the “Amendment Date”), the Company entered into an amendment (the “Repricing Amendment”) to the Credit Agreement. As a result of the Repricing Amendment, the interest rate on the Term Loan was reduced and, as of the Amendment Date, such loans had an interest rate equal to, at the Company's option, either LIBOR plus an applicable margin of 3.50% or a base rate plus an applicable margin of 2.50%. The Repricing Amendment did not change the interest rate on the Revolving Credit Facility. The Revolving Credit Facility continued to bear interest based upon the Company's consolidated net leverage ratio as of the last financial statements delivered to the administrative agent. No additional debt was incurred, or any proceeds received, by the Company in connection with the Repricing Amendment. The incremental fees paid to the administrative agent are reflected as additional debt discount and are amortized over the terms of the long-term financing agreements using the effective-interest method. On November 7, 2019, the Company entered into an amendment (the “Incremental Facility Amendment”) to the Credit Agreement to increase the principal borrowed on the Term Facility by $460.0 million. The Term Facility together with the incremental borrowing make up the Initial Term Loans (as defined in the Incremental Facility Amendment) and as of the Amendment No. 2 Effective Date (as defined in the Incremental Facility Amendment), the Initial Term Loans bear interest at a rate equal to, at the Company's option, either LIBOR plus an applicable margin of 3.75% or a base rate plus an applicable margin of 2.75%. The Incremental Facility Amendment was executed to partially finance the Acquisition of Quest. No amounts under the Term Facility were repaid as a result of the execution of the Incremental Facility Amendment. The Credit Agreement contains certain financial and other covenants that limit our ability to, among other things, incur and/or undertake asset sales and other dispositions, liens, indebtedness, certain acquisitions and investments, consolidations, mergers, reorganizations and other fundamental changes, payment of dividends and other distributions to equity and warrant holders, and prepayments of material subordinated debt, in each case, subject to customary exceptions materially consistent with credit facilities of such type and size. The Revolving Credit Facility has a maximum total net leverage ratio equal to or less than 6.25:1.00 (with a reduction to 6.00:1.00 on and after the third anniversary of the closing date of the Credit Agreement) contingent on credit extensions in excess of 30% of the total amount of commitments available under the Revolving Credit Facility. Any failure to comply with the restrictions of the credit facilities may result in an event of default. The Company was in compliance with all financial covenants as of February 27, 2021 and August 29, 2020, respectively. Long-term debt consists of the following: (In thousands) February 27, 2021 August 29, 2020 Term Facility (effective rate of 4.8% at February 27, 2021) $ 556,500 $ 606,500 Finance lease liabilities (effective rate of 5.6% at February 27, 2021) 826 922 Less: Deferred financing fees 8,164 10,272 Total debt 549,162 597,150 Less: Current finance lease liabilities 278 271 Long-term debt, net of deferred financing fees $ 548,884 $ 596,879 The Company is not required to make principal payments on the Term Facility over the twelve months following the period ended February 27, 2021. The outstanding balance of the Term Facility is due upon its maturity in July 2024. Additionally, as of February 27, 2021 and August 29, 2020, there were no amounts drawn against the Revolving Credit Facility. As of February 27, 2021, the Company had letters of credit in the amount of $4.2 million outstanding. These letters of credit offset against the availability of the Revolving Credit Facility and exist to support three of the Company's leased buildings and insurance programs relating to workers' compensation. No amounts were drawn against these letters of credit at February 27, 2021. The Company utilizes market approaches to estimate the fair value of certain outstanding borrowings by discounting anticipated future cash flows derived from the contractual terms of the obligations and observable market interest and foreign exchange rates. The Company carries debt at historical cost and discloses fair value. As of February 27, 2021 and August 29, 2020, the book value of the Company’s debt approximated fair value. The estimated fair value of the Term Loan is valued based on observable inputs and classified as Level 2 in the fair value hierarchy.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Feb. 27, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measurements, a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies, is as follows: Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 – Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 – Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment. The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable approximated fair value as of February 27, 2021 and August 29, 2020 due to the relatively short maturity of these instruments.

Income Taxes

Income Taxes	6 Months Ended
	Feb. 27, 2021
Income Tax Disclosure [Abstract]
Income Taxes	The tax expense and the effective tax rate resulting from operations were as follows: Twenty-Six Weeks Ended (In thousands) February 27, 2021 February 29, 2020 Income before income taxes $ 57,307 $ 8,057 Income tax expense $ 15,687 $ 2,193 Effective tax rate 27.4 % 27.2 % The effective tax rate for the twenty-six weeks ended February 27, 2021 was 0.2% greater than the effective tax rate for the twenty-six weeks ended February 29, 2020, which was primarily driven by permanent differences.

Leases

Leases	6 Months Ended
	Feb. 27, 2021
Leases [Abstract]
Leases of Lessee Disclosure [Text Block]	The components of lease expense were as follows: Thirteen Weeks Ended Twenty-Six Weeks Ended (In thousands) Statement of Operations Caption February 27, 2021 February 29, 2020 February 27, 2021 February 29, 2020 Operating lease cost: Lease cost Cost of goods sold and General and administrative $ 1,496 $ 1,441 $ 2,994 $ 2,247 Variable lease cost (1) Cost of goods sold and General and administrative 378 426 776 736 Operating lease cost 1,874 1,867 3,770 2,983 Short term lease cost General and administrative — 18 — 24 Finance lease cost: Amortization of right-of-use assets Cost of goods sold 68 66 136 136 Interest on lease liabilities Interest expense 12 16 25 32 Total finance lease cost 80 82 161 168 Total lease cost $ 1,954 $ 1,967 $ 3,931 $ 3,175 (1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs. In conjunction with the Company's restructuring activities as discussed in Note 14, the Company incurred impairment charges of $0.3 million and $0.7 million in the thirteen and twenty-six weeks ended February 27, 2021, respectively, related to its operating lease right-of-use assets for leases in Toronto, Ontario and the Netherlands. Additionally, the Company terminated the lease in Toronto, Ontario, which resulted in a gain on lease termination of $0.2 million in the thirteen and twenty-six weeks ended February 27, 2021. The effect of these restructuring activities has been included within General and administrative on the Consolidated Statements of Operations and Comprehensive Income. Refer to Note 14, Restructuring and Related Charges, for additional information regarding restructuring activities. The gross amounts of assets and liabilities related to both operating and finance leases are as follows: (In thousands) Balance Sheet Caption February 27, 2021 August 29, 2020 Assets Operating lease right-of-use assets Other long-term assets $ 23,089 $ 25,703 Finance lease right-of-use assets Property and equipment, net 776 912 Total lease assets $ 23,865 $ 26,615 Liabilities Current: Operating lease liabilities Accrued expenses and other current liabilities $ 4,235 $ 4,329 Finance lease liabilities Current maturities of long-term debt 278 271 Long-term: Operating lease liabilities Other long-term liabilities 20,880 22,764 Finance lease liabilities Long-term debt, less current maturities 548 651 Total lease liabilities $ 25,941 $ 28,015 Future maturities of lease liabilities as of February 27, 2021 were as follows: (In thousands) Operating Leases Finance Leases Fiscal year ending: Remainder of 2021 $ 2,935 $ 157 2022 4,607 313 2023 4,071 278 2024 4,232 145 2025 3,838 — Thereafter 11,050 — Total lease payments 30,733 893 Less: Interest (5,618) (67) Present value of lease liabilities $ 25,115 $ 826 As of February 27, 2021, the Company had entered into a lease with estimated total minimum future lease payments of $32.2 million over a 10.0-year minimum lease term that had not yet commenced, and as a result it is not recorded on the Consolidated Balance Sheets. The Company expects the lease to commence in fiscal year 2021, and the Company has the option to renew the lease for an additional 5.0 years or 10.0 years after the minimum lease term. The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases were as follows: February 27, 2021 August 29, 2020 Weighted-average remaining lease term (in years) Operating leases 6.76 6.97 Finance leases 2.92 3.41 Weighted-average discount rate Operating leases 5.8 % 5.7 % Finance leases 5.6 % 5.6 % Supplemental and other information related to leases was as follows: Twenty-Six Weeks Ended (In thousands) February 27, 2021 February 29, 2020 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 3,689 $ 2,817 Operating cash flows from finance leases 12 9 Financing cash flows from finance leases $ 157 $ 157

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Feb. 27, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Litigation The Company is a party to certain litigation and claims that are considered normal to the operations of the business. From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any litigation that it believes to be material, and the Company is not aware of any pending or threatened litigation against it that its management believes could have a material adverse effect on its business, operating result, financial condition or cash flows. During the fiscal year ended August 31, 2019, the Company reserved $3.5 million for the potential settlement of class action litigation concerning certain product label claims. During the twenty-six weeks ended February 29, 2020, the Company reserved an additional $0.3 million. The reserve was included within General and administrative in the Consolidated Statements of Operations and Comprehensive Income, and the reserve was fully paid into escrow and settled during the fiscal year ended August 29, 2020. As of February 27, 2021 and August 29, 2020, the Company had $0.7 million and $1.3 million reserved for potential settlements, respectively. Other The Company has entered into endorsement contracts with certain celebrity figures and social media influencers to promote and endorse the Atkins and Quest brands and product lines. These contracts contain endorsement fees, which are expensed ratably over the life of the contract, and performance fees, that are recognized at the time of achievement. Based on the terms of the contracts in place and achievement of performance conditions as of February 27, 2021, the Company will be required to make payments of $2.8 million over the next year.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Feb. 27, 2021
Equity [Abstract]
Stockholders' Equity	Public Equity Offering On October 9, 2019, the Company completed an underwritten public offering of 13,379,205 shares of common stock at a price to the public of $26.35 per share. The Company paid underwriting discounts and commissions of $0.19 per share resulting in net proceeds to the Company of $26.16 per share, or approximately $350.0 million (the “Offering”). The Company paid $0.8 million for legal, accounting and registrations fees related to the Offering. The net proceeds were used to pay a portion of the purchase price and related fees and expenses for the Acquisition of Quest. Equity Warrants Prior to the Acquisition of Atkins, Conyers Park issued 6,700,000 private placement warrants. The Company assumed these private placement warrants in connection with the Acquisition of Atkins. As a result of the Acquisition of Atkins, the warrants issued by Conyers Park were no longer exercisable for shares of Conyers Park common stock, but were instead exercisable for common stock of the Company. All other features of the warrants were unchanged. As of February 27, 2021, the private placement warrants to purchase 6,700,000 shares of the Company’s common stock remain outstanding. Stock Repurchase Program On November 13, 2018, the Company announced that its Board of Directors had adopted a $50.0 million stock repurchase program. Under the stock repurchase program, the Company may repurchase shares from time to time in the open market or in privately negotiated transactions. The stock repurchase program does not obligate the Company to acquire any specific number of shares or acquire shares over any specific period of time. The stock repurchase program may be suspended or discontinued at any time by the Company and does not have an expiration date.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Feb. 27, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Basic earnings per share is based on the weighted average number of common shares issued and outstanding. In periods in which the Company has net income, diluted earnings per share is based on the weighted average number of common shares issued and outstanding and the effect of all dilutive common stock equivalents outstanding during each period. In periods in which the Company has a net loss, diluted earnings per share is based on the weighted average number of common shares issued and outstanding as the effect of including common stock equivalents outstanding would be anti-dilutive. The following table reconciles the numerators and denominators used in the computations of both basic and diluted earnings per share: Thirteen Weeks Ended Twenty-Six Weeks Ended (In thousands, except per share data) February 27, 2021 February 29, 2020 February 27, 2021 February 29, 2020 Basic earnings per share computation: Numerator: Net income $ 19,120 $ 10,657 $ 41,620 $ 5,864 Denominator: Weighted average common shares - basic 95,734,591 95,339,489 95,712,057 92,524,061 Basic earnings per share from net income $ 0.20 $ 0.11 $ 0.43 $ 0.06 Diluted earnings per share computation: Numerator: Net income $ 19,120 $ 10,657 $ 41,620 $ 5,864 Denominator: Weighted average common shares outstanding - basic 95,734,591 95,339,489 95,712,057 92,524,061 Public and Private Warrants 3,928,303 3,706,986 3,607,125 3,766,141 Employee stock options 1,205,376 1,173,631 1,056,707 1,194,968 Non-vested shares 284,626 116,465 228,248 112,444 Weighted average common shares - diluted 101,152,896 100,336,571 100,604,137 97,597,614 Diluted earnings per share from net income $ 0.19 $ 0.11 $ 0.41 $ 0.06 Earnings per share calculations for the thirteen weeks ended February 27, 2021 and February 29, 2020 excluded 0.2 million and 0.4 million shares underlying stock options issuable upon exercise, respectively, that would have been anti-dilutive. Earnings per share calculations for the thirteen weeks ended February 27, 2021 excluded an immaterial number of non-vested shares that would have been anti-dilutive.

Omnibus Incentive Plan

Omnibus Incentive Plan	6 Months Ended
	Feb. 27, 2021
Share-based Payment Arrangement [Abstract]
Stock Option Plan	Stock-based compensation includes stock options, restricted stock units, performance stock unit awards and stock appreciation rights, which are awarded to employees, directors, and consultants of the Company. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the award based on their grant date fair value. Stock-based compensation expense is included within General and administrative expense, which is the same financial statement caption where the recipient’s other compensation is reported. Stock Options The following table summarizes stock option activity for the twenty-six weeks ended February 27, 2021: Shares Underlying Options Weighted Average Weighted Average Remaining Contractual Life (Years) Outstanding as of August 29, 2020 2,615,899 $ 14.33 Granted 289,555 20.47 Exercised (43,928) 12.00 Forfeited (39,575) 23.08 Outstanding as of February 27, 2021 2,821,951 $ 14.88 7.11 Vested and expected to vest as of February 27, 2021 2,821,951 $ 14.88 7.11 Exercisable as of February 27, 2021 2,197,655 $ 13.24 6.61 As of February 27, 2021, the Company had $3.5 million of total unrecognized compensation cost related to stock option plans that will be recognized over a weighted average period of 1.9 years. During the twenty-six weeks ended February 27, 2021 and February 29, 2020, the Company received $0.5 million and $0.9 million in cash from stock option exercises, respectively. Restricted Stock Units The following table summarizes restricted stock unit activity for the twenty-six weeks ended February 27, 2021: Restricted Stock Units Weighted average Non-vested as of August 29, 2020 208,023 $ 22.82 Granted 311,873 21.57 Vested (72,568) 25.89 Forfeited (15,706) 22.99 Non-vested as of February 27, 2021 431,622 $ 21.39 As of February 27, 2021, the Company had $7.6 million of total unrecognized compensation cost related to restricted stock units that will be recognized over a weighted average period of 2.2 years. Performance Stock Units During the twenty-six weeks ended February 27, 2021, the Board of Directors granted performance stock units under the Company’s equity compensation plan. Performance stock units vest in a range between 0% and 200% based upon certain performance criteria in a three The following table summarizes performance stock unit activity for the twenty-six weeks ended February 27, 2021: Performance Stock Units Weighted average Non-vested as of August 29, 2020 295,256 $ 17.93 Granted 116,309 23.59 Vested — — Forfeited (26,400) 22.06 Non-vested as of February 27, 2021 385,165 $ 19.35 As of February 27, 2021, the Company had $4.4 million of total unrecognized compensation cost related to performance stock units that will be recognized over a weighted average period of 1.6 years. Stock Appreciation Rights Stock appreciation rights ("SARs") permit the holder to participate in the appreciation of the Company's common stock price. The Company's SARs settle in shares of its common stock once the applicable vesting criteria has been met. SARs cliff vest 3 years from the date of grant and must be exercised within 10 years. The following table summarizes SARs activity for the twenty-six weeks ended February 27, 2021: Shares Underlying SARs Weighted average Weighted average remaining contractual life (in years) Outstanding as of August 29, 2020 150,000 $ 24.20 Granted — — Exercised — — Forfeited — — Outstanding as of February 27, 2021 150,000 $ 24.20 8.68 Vested and expected to vest as of February 27, 2021 150,000 $ 24.20 8.68 Exercisable as of February 27, 2021 — $ — 0.00

Restructuring and Related Charg

Restructuring and Related Charges	6 Months Ended
	Feb. 27, 2021
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	In May 2020, the Company announced certain restructuring activities in conjunction with the implementation of the Company’s future-state organization design, which created a fully integrated organization with its completed Acquisition of Quest. The new organization design became effective on August 31, 2020. These restructuring plans primarily include workforce reductions, changes in management structure, and the relocation of business activities from one location to another. The one-time termination benefits and employee severance costs to be incurred in relation to these restructuring activities are accounted for in accordance with ASC Topic 420, Exit or Disposal Cost Obligations, and ASC Topic 712, Compensation-Nonretirement Postemployment Benefits, respectively. The Company recognizes a liability and the related expense for these restructuring costs when the liability is incurred and can be measured. Restructuring accruals are based upon management estimates at the time and can change depending upon changes in facts and circumstances subsequent to the date the original liability was recorded. Changes to the restructuring liability during the twenty-six weeks ended February 27, 2021 were as follows: (in thousands) Termination benefits and severance Other Restructuring Liability Balance as of August 29, 2020 $ 4,139 $ — $ 4,139 Charges 3,118 144 3,262 Cash payments (6,146) (144) (6,290) Non-cash settlements or adjustments — — — Balance as of February 27, 2021 $ 1,111 $ — $ 1,111 In addition to the restructuring costs shown above, the Company incurred impairment charges of $0.3 million and $0.7 million in the thirteen and twenty-six weeks ended February 27, 2021, respectively, related to its operating lease right-of-use assets for leases in Toronto, Ontario and the Netherlands. Additionally, the Company terminated the lease in Toronto, Ontario, which resulted in a gain on lease termination of $0.2 million in the thirteen and twenty-six weeks ended February 27, 2021. As a result, for the thirteen and twenty-six weeks ended February 27, 2021, the Company incurred a total of $1.3 million and $3.8 million in restructuring and restructuring related costs, respectively, which have been included within General and administrative on the Consolidated Statements of Operations and Comprehensive Income. As of February 27, 2021, the Company has incurred aggregate restructuring and restructuring-related costs of $9.3 million since May 2020. Overall, the Company expects to incur a total of approximately $10.0 million in restructuring and restructuring related costs, which are to be paid throughout fiscal 2021 and the first quarter of fiscal 2022.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Feb. 27, 2021
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued and Adopted Accounting Pronouncements Recently Issued Accounting Pronouncements Not Yet Adopted In December 2019, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which amends the existing guidance relating to the accounting for income taxes. This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of U.S. GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2021, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not expect that the adoption of this ASU will be material to its consolidated financial statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. The amendments in this ASU are effective for all entities and can be applied to contract modifications due to rate reform and eligible existing and new hedging relationships entered into between March 12, 2020 through December 31, 2022. The amendments of this ASU should be applied on a prospective basis. The Company will continue to monitor the effects of rate reform, if any, on its contracts and the effects of adoption of this ASU through December 31, 2022. The Company does not anticipate the amendments in this ASU to be material to its consolidated financial statements. In October 2020, the FASB issued ASU No. 2020-10, Codification Improvements, which provides updates for technical corrections, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements across various areas of accounting within U.S. GAAP. This ASU is effective for all entities for fiscal years beginning after December 15, 2020, with early adoption permitted. The amendments of this ASU should be applied retrospectively. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not anticipate the adoption of this ASU will be material to its consolidated financial statements. Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326), which modified the measurement of expected credit losses of certain financial instruments. The Company adopted this ASU as of the first day of fiscal 2021. As a result of adopting this ASU, the Company changed its method of estimating its allowance for doubtful accounts for trade receivables to be based upon the Company's historical credit loss experience adjusted for asset-specific risk characteristics, current economic conditions, and reasonable forecasts. The change in estimating the allowance for doubtful accounts did not have a material effect on the Company's consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modified disclosure requirements on fair value measurements of Accounting Standards Codification (“ASC”) 820. The Company adopted this ASU as of the first day of fiscal 2021. The adoption of this ASU did not have a material effect on the consolidated financial statements or the related disclosures.
Basis of Accounting, Policy [Policy Text Block]	Unaudited Interim Condensed Consolidated Financial Statements The unaudited interim condensed consolidated financial statements include the accounts of Simply Good Foods and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated. Unless the context otherwise requires, “we,” “us,” “our” and the “Company” refer to Simply Good Foods and its subsidiaries. The Company maintains its accounting records on a 52/53-week fiscal year, ending on the last Saturday in August of each year. The interim condensed consolidated financial statements and related notes of the Company and its subsidiaries are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The unaudited interim condensed consolidated financial statements reflect all adjustments and disclosures which are, in the Company's opinion, necessary for a fair presentation of the results of operations, financial position and cash flows for the indicated periods. All such adjustments were of a normal and recurring nature unless otherwise disclosed. The year-end balance sheet data was derived from the audited financial statements and, in accordance with the instructions to Form 10-Q, certain information and footnote disclosures required by GAAP have been condensed or omitted. The results reported in these unaudited interim condensed consolidated financial statements are not necessarily indicative of the results that may be reported for the entire fiscal year and should be read in conjunction with the Company's consolidated financial statements for the fiscal year ended August 29, 2020, included in our Annual Report on Form 10-K (“Annual Report”), filed with the SEC on October 28, 2020. The Company remains uncertain of the ultimate effect COVID-19 could have on its business notwithstanding the distribution of several U.S. government approved vaccines and various federal, state and local governments having begun to ease the movement restrictions and public health initiatives while continuing to adhere to enhanced safety measures, such as physical distancing and face mask protocols. This uncertainty as to the duration and severity of economic effects from the COVID-19 pandemic stems from the potential for, among other things, (i) continued rates of reported cases of COVID-19 and the potential for mutations of COVID-19 to result in increased rates of reported cases for which currently approved vaccines are not effective, (ii) unexpected supply chain disruptions, (iii) changes to customer operations, (iv) continued or additional changes in consumer purchasing and consumption behavior beyond those evidenced to date, and (v) the closure of customer establishments.

Business Combination (Tables)

Business Combination (Tables)	6 Months Ended
	Feb. 27, 2021
Business Combinations [Abstract]
Schedule of Business Acquisitions, by Acquisition	The following table sets forth the final purchase price allocation of the Acquisition of Quest to the estimated fair value of the net assets acquired at the date of acquisition, in thousands: Assets acquired: Cash and cash equivalents $ 4,745 Accounts receivable, net 25,359 Inventories 44,032 Prepaid assets 1,214 Other current assets 3,812 Property and equipment, net (1) 9,843 Intangible assets, net (2) 868,375 Other long-term assets 20,997 Liabilities assumed: Accounts payable 25,200 Other current liabilities 11,237 Deferred income taxes (3) 10,754 Other long-term liabilities 18,891 Total identifiable net assets 912,295 Goodwill (4) 74,525 Total assets acquired and liabilities assumed $ 986,820
Business Combination, Revenues of Acquired Entity	The results of Quest's operations have been included in the Company's Consolidated Financial Statements since November 7, 2019, the date of acquisition. The following table provides net sales from the acquired Quest business included in the Company's results: Thirteen Weeks Ended Twenty-Six Weeks Ended (in thousands) February 27, 2021 February 29, 2020 February 27, 2021 February 29, 2020 Net sales (1) $ 105,025 $ 88,305 $ 200,794 $ 105,387
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial information presents the combined results of the Company and Quest as if the Acquisition of Quest has occurred at the beginning of fiscal 2019: Thirteen Weeks Ended Twenty-Six Weeks Ended (in thousands) February 29, 2020 February 29, 2020 Revenue $ 227,101 $ 447,657 Gross profit $ 90,479 $ 178,667 Net income $ 15,049 $ 30,697

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Feb. 27, 2021
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Revenues from transactions with external customers for each of the Company’s products would be impracticable to disclose and management does not view its business by product line. The following is a summary of revenue disaggregated by geographic area and core brands: Thirteen Weeks Ended Twenty-Six Weeks Ended (In thousands) February 27, 2021 February 29, 2020 February 27, 2021 February 29, 2020 North America Atkins $ 114,155 $ 131,435 $ 236,916 $ 259,247 Quest (2) 105,025 88,305 200,794 105,387 Total North America (1) 219,180 219,740 437,710 364,634 International 11,427 7,361 24,049 14,620 Total net sales $ 230,607 $ 227,101 $ 461,759 $ 379,254 (1) Revenue within the North America geographic area substantially relates to the United States and includes the divested SimplyProtein brand. (2) Quest net sales are primarily in North America.

Goodwill and Intangibles (Table

Goodwill and Intangibles (Tables)	6 Months Ended
	Feb. 27, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Changes to Goodwill during the thirteen week period ended February 27, 2021 were as follows: (in thousands) Goodwill Balance as of August 29, 2020 $ 544,774 Acquisition of business, measurement period adjustment 1,178 Sale of business (2,818) Balance as of February 27, 2021 $ 543,134
Schedule of Finite-Lived Intangible Assets	Intangible assets, net in the Consolidated Balance Sheets consist of the following: February 27, 2021 (In thousands) Useful life Gross carrying amount Accumulated amortization Net carrying amount Intangible assets with indefinite life: Brands and trademarks Indefinite life $ 974,000 $ — $ 974,000 Intangible assets with finite lives: Customer relationships 15 years 174,000 24,303 149,697 Proprietary recipes and formulas 7 years 7,000 3,631 3,369 Licensing agreements 14 years 22,000 5,706 16,294 Software and website development costs 3 - 5 years 5,302 2,678 2,624 Intangible assets in progress 3 - 5 years 55 — 55 $ 1,182,357 $ 36,318 $ 1,146,039 August 29, 2020 (In thousands) Useful life Gross carrying amount Accumulated amortization Net carrying amount Intangible assets with indefinite life: Brands and trademarks Indefinite life $ 979,000 $ — $ 979,000 Intangible assets with finite lives: Customer relationships 15 years 174,000 18,503 155,497 Proprietary recipes and formulas 7 years 7,000 3,131 3,869 Licensing agreements 14 years 22,000 4,920 17,080 Software and website development costs 3 - 5 years 5,967 2,645 3,322 $ 1,187,967 $ 29,199 $ 1,158,768
Schedule of Indefinite-Lived Intangible Assets	Intangible assets, net in the Consolidated Balance Sheets consist of the following: February 27, 2021 (In thousands) Useful life Gross carrying amount Accumulated amortization Net carrying amount Intangible assets with indefinite life: Brands and trademarks Indefinite life $ 974,000 $ — $ 974,000 Intangible assets with finite lives: Customer relationships 15 years 174,000 24,303 149,697 Proprietary recipes and formulas 7 years 7,000 3,631 3,369 Licensing agreements 14 years 22,000 5,706 16,294 Software and website development costs 3 - 5 years 5,302 2,678 2,624 Intangible assets in progress 3 - 5 years 55 — 55 $ 1,182,357 $ 36,318 $ 1,146,039 August 29, 2020 (In thousands) Useful life Gross carrying amount Accumulated amortization Net carrying amount Intangible assets with indefinite life: Brands and trademarks Indefinite life $ 979,000 $ — $ 979,000 Intangible assets with finite lives: Customer relationships 15 years 174,000 18,503 155,497 Proprietary recipes and formulas 7 years 7,000 3,131 3,869 Licensing agreements 14 years 22,000 4,920 17,080 Software and website development costs 3 - 5 years 5,967 2,645 3,322 $ 1,187,967 $ 29,199 $ 1,158,768
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	Estimated future amortization for each of the next five fiscal years and thereafter is as follows: (In thousands) Amortization Remainder of 2021 $ 7,674 2022 15,224 2023 14,938 2024 14,257 2025 13,171 2026 and thereafter 106,720 Total $ 171,984

Long-Term Debt and Line of Cr_2

Long-Term Debt and Line of Credit (Tables)	6 Months Ended
	Feb. 27, 2021
Debt Disclosure [Abstract]
Schedule of Debt	Long-term debt consists of the following: (In thousands) February 27, 2021 August 29, 2020 Term Facility (effective rate of 4.8% at February 27, 2021) $ 556,500 $ 606,500 Finance lease liabilities (effective rate of 5.6% at February 27, 2021) 826 922 Less: Deferred financing fees 8,164 10,272 Total debt 549,162 597,150 Less: Current finance lease liabilities 278 271 Long-term debt, net of deferred financing fees $ 548,884 $ 596,879

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Feb. 27, 2021
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation	The tax expense and the effective tax rate resulting from operations were as follows: Twenty-Six Weeks Ended (In thousands) February 27, 2021 February 29, 2020 Income before income taxes $ 57,307 $ 8,057 Income tax expense $ 15,687 $ 2,193 Effective tax rate 27.4 % 27.2 %

Leases (Tables)

Leases (Tables)	6 Months Ended
	Feb. 27, 2021
Leases [Abstract]
Lease, Cost	The components of lease expense were as follows: Thirteen Weeks Ended Twenty-Six Weeks Ended (In thousands) Statement of Operations Caption February 27, 2021 February 29, 2020 February 27, 2021 February 29, 2020 Operating lease cost: Lease cost Cost of goods sold and General and administrative $ 1,496 $ 1,441 $ 2,994 $ 2,247 Variable lease cost (1) Cost of goods sold and General and administrative 378 426 776 736 Operating lease cost 1,874 1,867 3,770 2,983 Short term lease cost General and administrative — 18 — 24 Finance lease cost: Amortization of right-of-use assets Cost of goods sold 68 66 136 136 Interest on lease liabilities Interest expense 12 16 25 32 Total finance lease cost 80 82 161 168 Total lease cost $ 1,954 $ 1,967 $ 3,931 $ 3,175
Lease assets and liabilities	The gross amounts of assets and liabilities related to both operating and finance leases are as follows: (In thousands) Balance Sheet Caption February 27, 2021 August 29, 2020 Assets Operating lease right-of-use assets Other long-term assets $ 23,089 $ 25,703 Finance lease right-of-use assets Property and equipment, net 776 912 Total lease assets $ 23,865 $ 26,615 Liabilities Current: Operating lease liabilities Accrued expenses and other current liabilities $ 4,235 $ 4,329 Finance lease liabilities Current maturities of long-term debt 278 271 Long-term: Operating lease liabilities Other long-term liabilities 20,880 22,764 Finance lease liabilities Long-term debt, less current maturities 548 651 Total lease liabilities $ 25,941 $ 28,015
Finance Lease, Liability, Maturity	Future maturities of lease liabilities as of February 27, 2021 were as follows: (In thousands) Operating Leases Finance Leases Fiscal year ending: Remainder of 2021 $ 2,935 $ 157 2022 4,607 313 2023 4,071 278 2024 4,232 145 2025 3,838 — Thereafter 11,050 — Total lease payments 30,733 893 Less: Interest (5,618) (67) Present value of lease liabilities $ 25,115 $ 826
Lessee, Operating Lease, Liability, Maturity	Future maturities of lease liabilities as of February 27, 2021 were as follows: (In thousands) Operating Leases Finance Leases Fiscal year ending: Remainder of 2021 $ 2,935 $ 157 2022 4,607 313 2023 4,071 278 2024 4,232 145 2025 3,838 — Thereafter 11,050 — Total lease payments 30,733 893 Less: Interest (5,618) (67) Present value of lease liabilities $ 25,115 $ 826
Schedule of Weighted Average Remaining Lease Terms	The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases were as follows: February 27, 2021 August 29, 2020 Weighted-average remaining lease term (in years) Operating leases 6.76 6.97 Finance leases 2.92 3.41 Weighted-average discount rate Operating leases 5.8 % 5.7 % Finance leases 5.6 % 5.6 %
Schedule of Supplemental Cash Flow Information Related to Leases	Supplemental and other information related to leases was as follows: Twenty-Six Weeks Ended (In thousands) February 27, 2021 February 29, 2020 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 3,689 $ 2,817 Operating cash flows from finance leases 12 9 Financing cash flows from finance leases $ 157 $ 157

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Feb. 27, 2021
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table reconciles the numerators and denominators used in the computations of both basic and diluted earnings per share: Thirteen Weeks Ended Twenty-Six Weeks Ended (In thousands, except per share data) February 27, 2021 February 29, 2020 February 27, 2021 February 29, 2020 Basic earnings per share computation: Numerator: Net income $ 19,120 $ 10,657 $ 41,620 $ 5,864 Denominator: Weighted average common shares - basic 95,734,591 95,339,489 95,712,057 92,524,061 Basic earnings per share from net income $ 0.20 $ 0.11 $ 0.43 $ 0.06 Diluted earnings per share computation: Numerator: Net income $ 19,120 $ 10,657 $ 41,620 $ 5,864 Denominator: Weighted average common shares outstanding - basic 95,734,591 95,339,489 95,712,057 92,524,061 Public and Private Warrants 3,928,303 3,706,986 3,607,125 3,766,141 Employee stock options 1,205,376 1,173,631 1,056,707 1,194,968 Non-vested shares 284,626 116,465 228,248 112,444 Weighted average common shares - diluted 101,152,896 100,336,571 100,604,137 97,597,614 Diluted earnings per share from net income $ 0.19 $ 0.11 $ 0.41 $ 0.06

Omnibus Incentive Plan (Tables)

Omnibus Incentive Plan (Tables)	6 Months Ended
	Feb. 27, 2021
Share-based Payment Arrangement [Abstract]
Stock option activity	The following table summarizes stock option activity for the twenty-six weeks ended February 27, 2021: Shares Underlying Options Weighted Average Weighted Average Remaining Contractual Life (Years) Outstanding as of August 29, 2020 2,615,899 $ 14.33 Granted 289,555 20.47 Exercised (43,928) 12.00 Forfeited (39,575) 23.08 Outstanding as of February 27, 2021 2,821,951 $ 14.88 7.11 Vested and expected to vest as of February 27, 2021 2,821,951 $ 14.88 7.11 Exercisable as of February 27, 2021 2,197,655 $ 13.24 6.61
Restricted stock activity	The following table summarizes restricted stock unit activity for the twenty-six weeks ended February 27, 2021: Restricted Stock Units Weighted average Non-vested as of August 29, 2020 208,023 $ 22.82 Granted 311,873 21.57 Vested (72,568) 25.89 Forfeited (15,706) 22.99 Non-vested as of February 27, 2021 431,622 $ 21.39
Performance stock unit activity	The following table summarizes performance stock unit activity for the twenty-six weeks ended February 27, 2021: Performance Stock Units Weighted average Non-vested as of August 29, 2020 295,256 $ 17.93 Granted 116,309 23.59 Vested — — Forfeited (26,400) 22.06 Non-vested as of February 27, 2021 385,165 $ 19.35
Stock appreciation right activity	The following table summarizes SARs activity for the twenty-six weeks ended February 27, 2021: Shares Underlying SARs Weighted average Weighted average remaining contractual life (in years) Outstanding as of August 29, 2020 150,000 $ 24.20 Granted — — Exercised — — Forfeited — — Outstanding as of February 27, 2021 150,000 $ 24.20 8.68 Vested and expected to vest as of February 27, 2021 150,000 $ 24.20 8.68 Exercisable as of February 27, 2021 — $ — 0.00

Restructuring and related cha_2

Restructuring and related charges (Tables)	6 Months Ended
	Feb. 27, 2021
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	Changes to the restructuring liability during the twenty-six weeks ended February 27, 2021 were as follows: (in thousands) Termination benefits and severance Other Restructuring Liability Balance as of August 29, 2020 $ 4,139 $ — $ 4,139 Charges 3,118 144 3,262 Cash payments (6,146) (144) (6,290) Non-cash settlements or adjustments — — — Balance as of February 27, 2021 $ 1,111 $ — $ 1,111

Business Combination (Details)

Business Combination (Details) - USD ($) $ in Thousands	Nov. 07, 2019	Oct. 09, 2019	Feb. 27, 2021	Nov. 28, 2020	Aug. 29, 2020	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Business Acquisition [Line Items]
Payments to acquire business, equity issuance		$ 350,000
Business transaction costs			$ 0			$ 694	$ 0	$ 26,853
Acquisition of Quest
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 988,900
Total purchase price	986,820		$ 986,800				$ 986,800
Payments to acquire business, cash on hand	195,300
Payments to acquire business, equity issuance		$ 350,000
Proceeds from long-term line of credit	443,600
Business transaction costs								$ 26,900
Transaction advisory fees	14,500
Banker commitment fees	3,200
Non-deferrable debt issuance costs	6,100
Legal, due diligence and accounting fees	3,100
Intangible assets, net	868,375
Deferred income taxes	10,754
Property and equipment, net	9,843
Goodwill, Purchase Accounting Adjustments				$ 21,500
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred					$ 2,100
Acquisition of Quest | Deferred income taxes
Business Acquisition [Line Items]
Fair value measurement period adjustment				3,200
Acquisition of Quest | Intangible assets, net
Business Acquisition [Line Items]
Fair value measurement period adjustment				20,000
Acquisition of Quest | Accounts receivable, net
Business Acquisition [Line Items]
Fair value measurement period adjustment				(4,300)
Acquisition of Quest | Inventories
Business Acquisition [Line Items]
Fair value measurement period adjustment				900
Acquisition of Quest | Property and equipment, net
Business Acquisition [Line Items]
Fair value measurement period adjustment				$ (500)
Centerview Partners | Acquisition of Quest
Business Acquisition [Line Items]
Transaction advisory fees	12,000
Brands and trademarks | Acquisition of Quest
Business Acquisition [Line Items]
Intangible assets, net	750,000
Customer relationships | Acquisition of Quest
Business Acquisition [Line Items]
Intangible assets, net	115,000
Tax deductible goodwill	67,700
Software and website development costs | Acquisition of Quest
Business Acquisition [Line Items]
Intangible assets, net	3,400
Leasehold improvements | Acquisition of Quest
Business Acquisition [Line Items]
Property and equipment, net	6,900
Furniture and fixtures | Acquisition of Quest
Business Acquisition [Line Items]
Property and equipment, net	2,200
Equipment | Acquisition of Quest
Business Acquisition [Line Items]
Property and equipment, net	$ 700

Business Combination (Details 2

Business Combination (Details 2) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020	Aug. 29, 2020	Nov. 07, 2019
Business Combination, Description [Abstract]
Net sales	$ 230,607	$ 227,101	$ 461,759	$ 379,254
Business Combination, Consideration Transferred [Abstract]
Goodwill	543,134		543,134		$ 544,774
Acquisition of Quest
Business Combination, Consideration Transferred [Abstract]
Cash and equivalents						$ 4,745
Accounts receivable, net						25,359
Inventories						44,032
Prepaid assets						1,214
Other current assets						3,812
Property and equipment, net						9,843
Intangible assets, net						868,375
Other long-term assets						20,997
Accounts payable						25,200
Other current liabilities						11,237
Deferred income taxes						10,754
Other long-term liabilities						18,891
Total identifiable net assets						912,295
Goodwill						74,525
Total assets acquired and liabilities assumed	986,800		986,800			$ 986,820
Quest | Acquisition of Quest
Business Combination, Description [Abstract]
Net sales	$ 105,025	$ 88,305	$ 200,794	$ 105,387

Business Combination (Details 3

Business Combination (Details 3) - Acquisition of Quest - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Feb. 29, 2020	Feb. 29, 2020
Business Acquisition [Line Items]
Pro forma revenue	$ 447,657	$ 227,101
Pro forma gross profit	178,667	90,479
Pro forma net income (loss)	$ 30,697	$ 15,049

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Disaggregation of revenue
Net sales	$ 230,607	$ 227,101	$ 461,759	$ 379,254
North America
Disaggregation of revenue
Net sales	219,180	219,740	437,710	364,634
International
Disaggregation of revenue
Net sales	11,427	7,361	24,049	14,620
Atkins
Disaggregation of revenue
Net sales	114,155	131,435	236,916	259,247
Acquisition of Quest | Quest
Disaggregation of revenue
Net sales	$ 105,025	$ 88,305	$ 200,794	$ 105,387

Revenue Recognition (Details 2)

Revenue Recognition (Details 2) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Feb. 29, 2020	Feb. 29, 2020	Feb. 27, 2021	Aug. 29, 2020
Revenue from Contract with Customer [Abstract]
Allowance for doubtful accounts			$ 0.6	$ 0.5
Credit loss expense (reversal), accounts receivable	$ 0.1	$ 0.1

Goodwill and Intangibles Goodwi

Goodwill and Intangibles Goodwill Rollforward (Details) - USD ($) $ in Thousands	6 Months Ended
	Feb. 27, 2021	Aug. 29, 2020
Goodwill [Line Items]
Goodwill	$ 543,134	$ 544,774
Change in goodwill due to acquisition of a business	1,178
Goodwill disposed of with sale of business	$ (2,818)

Goodwill and Intangibles - Narr

Goodwill and Intangibles - Narrative (Details) - USD ($) $ in Thousands	Sep. 24, 2020	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Proceeds from SimplyProtein Sale	$ 8,800
Cash proceeds from SimplyProtein Sale	5,800
Note Receivable from SimplyProtein Sale	3,000
Gain (loss) on sale of business	0
Goodwill, Impaired, Accumulated Impairment Loss		$ 0		$ 0
Indefinite-lived intangible assets disposed of in sale of business	$ 5,000
Intangible asset amortization expense		$ 3,900	$ 3,900	7,700	$ 6,200
Impairment of intangible assets, excluding goodwill				$ 0

Goodwill and Intangibles - Sche

Goodwill and Intangibles - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Feb. 27, 2021	Aug. 29, 2020
Intangible assets with finite lives:
Intangible assets, Gross carrying amount	$ 1,182,357	$ 1,187,967
Accumulated amortization	36,318	29,199
Intangible assets, Net carrying amount	1,146,039	$ 1,158,768
Finite-lived intangible assets, Net carrying amount	$ 171,984
Customer relationships
Intangible assets with finite lives:
Useful life	15 years	15 years
Finite-lived intangible assets, Gross carrying amount	$ 174,000	$ 174,000
Accumulated amortization	24,303	18,503
Finite-lived intangible assets, Net carrying amount	149,697	155,497
Software and website development costs
Intangible assets with finite lives:
Finite-lived intangible assets, Gross carrying amount	5,302	5,967
Accumulated amortization	2,678	2,645
Finite-lived intangible assets, Net carrying amount	$ 2,624	$ 3,322
Proprietary recipes and formulas
Intangible assets with finite lives:
Useful life	7 years	7 years
Finite-lived intangible assets, Gross carrying amount	$ 7,000	$ 7,000
Accumulated amortization	3,631	3,131
Finite-lived intangible assets, Net carrying amount	$ 3,369	$ 3,869
Licensing agreements
Intangible assets with finite lives:
Useful life	14 years	14 years
Finite-lived intangible assets, Gross carrying amount	$ 22,000	$ 22,000
Accumulated amortization	5,706	4,920
Finite-lived intangible assets, Net carrying amount	16,294	$ 17,080
Intangible assets in progress
Intangible assets with finite lives:
Finite-lived intangible assets, Gross carrying amount	55
Accumulated amortization	0
Finite-lived intangible assets, Net carrying amount	$ 55
Minimum | Software and website development costs
Intangible assets with finite lives:
Useful life	3 years	3 years
Minimum | Intangible assets in progress
Intangible assets with finite lives:
Useful life	3 years
Maximum | Software and website development costs
Intangible assets with finite lives:
Useful life	5 years	5 years
Maximum | Intangible assets in progress
Intangible assets with finite lives:
Useful life	5 years
Brands and trademarks
Intangible assets with indefinite lives:
Indefinite-lived intangible assets	$ 974,000	$ 979,000

Goodwill and Intangibles - Sc_2

Goodwill and Intangibles - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Feb. 27, 2021USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2021	$ 7,674
2020	15,224
2021	14,938
2022	14,257
2023	13,171
2026 and thereafter	106,720
Finite-lived intangible assets, Net carrying amount	$ 171,984

Long-Term Debt and Line of Cr_3

Long-Term Debt and Line of Credit - Narrative (Details) - USD ($) $ in Millions	Nov. 07, 2019	Mar. 16, 2018	Jul. 07, 2017	Feb. 27, 2021	Aug. 29, 2020
Debt Instrument [Line Items]
Revolving Credit Facility, Amount Outstanding				$ 0	$ 0
Letters of Credit Outstanding, Amount				$ 4.2
Term Loan
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage				4.80%
Proceeds from long-term line of credit	$ 460
Repayments of principal in next twelve months				$ 0
Term Loan | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate	3.75%
Finance leases
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage				5.60%
Barclays Bank PLC and Other Parties | Term Loan
Debt Instrument [Line Items]
Borrowing capacity			$ 200
Maturity period			7 years
Barclays Bank PLC and Other Parties | Revolving Credit Facility
Debt Instrument [Line Items]
Borrowing capacity			$ 75
Maturity period			5 years
Net leverage ratio (equal to or less than)			6.25
Net leverage ratio post reduction (equal to or less than)			6
Percent of commitments (in excess of)			30.00%
Line of Credit | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
Line of Credit | Barclays Bank PLC and Other Parties | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate		2.50%	0.50%
Line of Credit | Barclays Bank PLC and Other Parties | Eurocurrency
Debt Instrument [Line Items]
Basis spread on variable rate			1.00%
Line of Credit | Barclays Bank PLC and Other Parties | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate		3.50%
Line of Credit | Barclays Bank PLC and Other Parties | Term Loan | Eurocurrency
Debt Instrument [Line Items]
Basis spread on variable rate			3.00%
Line of Credit | Barclays Bank PLC and Other Parties | Term Loan | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate			4.00%
Interest rate floor			1.00%
Line of Credit | Barclays Bank PLC and Other Parties | Revolving Credit Facility | Eurocurrency
Debt Instrument [Line Items]
Basis spread on variable rate			2.00%
Line of Credit | Barclays Bank PLC and Other Parties | Revolving Credit Facility | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate			3.00%

Long-Term Debt and Line of Cr_4

Long-Term Debt and Line of Credit - Schedule of Debt (Details) - USD ($) $ in Thousands	Feb. 27, 2021	Aug. 29, 2020
Debt Disclosure [Abstract]
Term Facility (effective rate of 4.8% at February 27, 2021)	$ 556,500	$ 606,500
Finance lease liabilities (effective rate of 5.6% at February 27, 2021)	826	922
Less: Deferred financing fees	8,164	10,272
Total debt	549,162	597,150
Less: Current finance lease liabilities	(278)	(271)
Long-term debt, net of deferred financing fees	$ 548,884	$ 596,879

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020
Income Tax Disclosure [Abstract]
Income before income taxes	$ 26,433	$ 14,579	$ 57,307	$ 8,057
Income tax expense	$ 7,313	$ 3,922	$ 15,687	$ 2,193
Effective tax rate			27.40%	27.20%

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details)	6 Months Ended
	Feb. 27, 2021
Income Tax Disclosure [Abstract]
Effective tax rate difference	0.20%

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 27, 2021	Feb. 29, 2020	Feb. 27, 2021	Feb. 29, 2020	Aug. 29, 2020
Components of lease expense
Lease cost	$ 1,496	$ 1,441	$ 2,994	$ 2,247
Variable lease cost (1)	378	426	776	736
Operating lease cost	1,874	1,867	3,770	2,983
Short term lease cost	0	18	0	24
Amortization of right-of-use assets	68	66	136	136
Interest on lease liabilities	12	16	25	32
Total finance lease cost	80	82	161	168
Total lease cost	1,954	$ 1,967	3,931	3,175
Assets and liabilities, lessee
Operating lease, right-of-use asset	23,089		23,089		$ 25,703
Finance lease, right-of-use asset	776		776		912
Total lease assets	23,865		23,865		26,615
Operating lease, liability, current	4,235		4,235		4,329
Finance lease, liability, current	278		278		271
Operating lease, liability, noncurrent	20,880		20,880		22,764
Finance lease, liability, noncurrent	548		548		651
Total lease liabilities	25,941		25,941		28,015
Future maturities of lease liabilities, operating leases
Remainder of 2021	2,935		2,935
2021	4,607		4,607
2022	4,071		4,071
2023	4,232		4,232
2024	3,838		3,838
Thereafter	11,050		11,050
Total lease payments	30,733		30,733
Less: Interest	(5,618)		(5,618)
Present value of lease liabilities	25,115		25,115
Future maturities of lease liabilities, finance leases
Remainder of 2021	157		157
2021	313		313
2022	278		278
2023	145		145
2024	0		0
Thereafter	0		0
Total lease payments	893		893
Less: Interest	(67)		(67)
Present value of lease liabilities	826		826		$ 922
Loss on operating lease right-of-use asset impairment	300		681	0
Lessee, Operating Lease, Lease Not Yet Commences, Expected Payments	$ 32,200		$ 32,200
Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract	10 years		10 years
Lessee, Lease, Description [Line Items]
Loss on operating lease right-of-use asset impairment	$ 300		$ 681	0
(Gain) loss on Termination of Lease			$ (154)	0
Finance Lease, Weighted Average Discount Rate, Percent	5.60%		5.60%		5.60%
Finance Lease, Weighted Average Remaining Lease Term	2 years 11 months 1 day		2 years 11 months 1 day		3 years 4 months 28 days
Operating Lease, Weighted Average Discount Rate, Percent	5.80%		5.80%		5.70%
Operating Lease, Weighted Average Remaining Lease Term	6 years 9 months 3 days		6 years 9 months 3 days		6 years 11 months 19 days
Supplemental and other information related to leases
Operating cash flows from operating leases			$ 3,689	2,817
Operating cash flows from finance leases			12	9
Financing cash flows from finance leases			$ 157	$ 157
Maximum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term	10 years		10 years
Minimum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term	5 years		5 years

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Feb. 29, 2020	Aug. 31, 2019	Feb. 27, 2021	Aug. 29, 2020
Commitments and Contingencies Disclosure [Abstract]
Litigation Settlement, Expense	$ 0.3	$ 3.5
Other commitment payment obligation			$ 2.8
Loss Contingency Accrual			$ 0.7	$ 1.3

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Millions	Oct. 09, 2019	Feb. 27, 2021	Feb. 29, 2020
Class of Stock [Line Items]
Shares, Issued	13,379,205
Shares issued price per share to public	$ 26.35
Underwriting discounts and commissions, Price per share	0.19
Shares issued proceeds per shares	$ 26.16
Proceeds from issuance of equity	$ 350
Equity Issuance costs, Legal	$ 0.8
Repurchase of common stock (in shares)		0	0
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 47.9
Private Placement Warrants
Class of Stock [Line Items]
Class of Warrant or Right, Outstanding		6,700,000
Treasury Stock
Class of Stock [Line Items]
Stock repurchase program, authorized amount		$ 50

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Feb. 27, 2021	Nov. 28, 2020	Feb. 29, 2020	Nov. 30, 2019	Feb. 27, 2021	Feb. 29, 2020
Numerator:
Net income	$ 19,120	$ 22,500	$ 10,657	$ (4,793)	$ 41,620	$ 5,864
Denominator:
Weighted average common shares - basic (in shares)	95,734,591		95,339,489		95,712,057	92,524,061
Basic earnings per share from net income (in dollars per share)	$ 0.20		$ 0.11		$ 0.43	$ 0.06
Numerator:
Net income	$ 19,120	$ 22,500	$ 10,657	$ (4,793)	$ 41,620	$ 5,864
Denominator:
Weighted average common shares - basic (in shares)	95,734,591		95,339,489		95,712,057	92,524,061
Public and Private Warrants	3,928,303		3,706,986		3,607,125	3,766,141
Employee stock options	1,205,376		1,173,631		1,056,707	1,194,968
Non-vested shares	284,626		116,465		228,248	112,444
Weighted average common shares - diluted (in shares)	101,152,896		100,336,571		100,604,137	97,597,614
Diluted earnings per share from net income (in dollars per share)	$ 0.19		$ 0.11		$ 0.41	$ 0.06
Stock Options
Earnings per share, diluted
Antidilutive securities excluded from computation of earnings per share	200,000		400,000		600,000	300,000

Omnibus Incentive Plan (Details

Omnibus Incentive Plan (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Feb. 27, 2021	Nov. 28, 2020	Feb. 29, 2020	Nov. 30, 2019	Feb. 27, 2021	Feb. 29, 2020
Share-based Compensation Arrangement by Share-based Payment Award
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	$ 2,484	$ 1,110	$ 2,122	$ 1,673
Stock compensation expense	$ 2,500		$ 2,100		$ 3,594	$ 3,795

Omnibus Incentive Plan - Stock

Omnibus Incentive Plan - Stock Options Activity (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Feb. 27, 2021USD ($)$ / sharesshares	Feb. 29, 2020USD ($)
Additional disclosures
Proceeds from option exercises | $	$ 527	$ 931
Stock Options
Shares
Outstanding at beginning of period (in shares) | shares	2,615,899
Granted (in shares) | shares	289,555
Exercised (in shares) | shares	(43,928)
Forfeited (in shares) | shares	(39,575)
Outstanding at end of period (in shares) | shares	2,821,951
Options vested or expected to vest (in shares) | shares	2,821,951
Exercisable (in shares) | shares	2,197,655
Weighted average exercise price
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 14.33
Granted (in dollars per share) | $ / shares	20.47
Exercised (in dollars per share) | $ / shares	12
Forfeited (in dollars per share) | $ / shares	23.08
Outstanding at end of period (in dollars per share) | $ / shares	14.88
Options vested or expected to vest (in dollars per share) | $ / shares	14.88
Exercisable (in dollars per share) | $ / shares	$ 13.24
Weighted average remaining contractual term
Outstanding at end of period, weighted average remaining contractual life	7 years 1 month 9 days
Vested and expected to vest at end of period, weighted average remaining contractual life	7 years 1 month 9 days
Exercisable at end of period, weighted average remaining contractual life	6 years 7 months 9 days
Additional disclosures
Unrecognized compensation costs | $	$ 3,500
Period for recognition of unrecognized compensation cost	1 year 10 months 24 days

Omnibus Incentive Plan - Restri

Omnibus Incentive Plan - Restricted Stock Units Activity (Details) - Restricted Stock Units $ / shares in Units, $ in Millions	6 Months Ended
	Feb. 27, 2021USD ($)$ / sharesshares
Units
Non-vested at beginning of period (in shares) | shares	208,023
Granted (in shares) | shares	311,873
Vested (in shares) | shares	(72,568)
Forfeited (in shares) | shares	(15,706)
Non-vested at end of period (in shares) | shares	431,622
Weighted average grant-date fair value
Non-vested at beginning of period (in dollars per share) | $ / shares	$ 22.82
Granted (in dollars per share) | $ / shares	21.57
Vested (in dollars per share) | $ / shares	25.89
Forfeited (in dollars per share) | $ / shares	22.99
Non-vested at end of period (in dollars per share) | $ / shares	$ 21.39
Additional disclosures
Unrecognized compensation costs | $	$ 7.6
Period for recognition of unrecognized compensation cost	2 years 2 months 12 days

Omnibus Incentive Plan - Perfor

Omnibus Incentive Plan - Performance Stock Units Activity (Details) - Performance Stock Units $ / shares in Units, $ in Millions	6 Months Ended
	Feb. 27, 2021USD ($)$ / sharesshares
Units
Non-vested at beginning of period (in shares) | shares	295,256
Granted (in shares) | shares	116,309
Vested (in shares) | shares	0
Forfeited (in shares) | shares	(26,400)
Non-vested at end of period (in shares) | shares	385,165
Weighted average grant-date fair value
Non-vested at beginning of period (in dollars per share) | $ / shares	$ 17.93
Granted (in dollars per share) | $ / shares	23.59
Vested (in dollars per share) | $ / shares	0
Forfeited (in dollars per share) | $ / shares	22.06
Non-vested at end of period (in dollars per share) | $ / shares	$ 19.35
Additional disclosures
Period for recognition of unrecognized compensation cost	1 year 7 months 6 days
Unrecognized compensation costs | $	$ 4.4
Requisite service period	3 years
Minimum
Additional disclosures
Performance stock vesting range	0.00%
Maximum
Additional disclosures
Performance stock vesting range	200.00%

Omnibus Incentive Plan - Stoc_2

Omnibus Incentive Plan - Stock Appreciation Rights (Activity) (Details) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Feb. 27, 2021
Additional disclosures
Award vesting period	3 years
Award expiration period	10 years
Stock Appreciation Rights (SARs)
Shares
Outstanding at beginning of period (in shares)	150,000
Granted (in shares)	0
Exercised (in shares)	0
Forfeited (in shares)	0
Outstanding at end of period (in shares)	150,000
Options vested or expected to vest (in shares)	150,000
Exercisable (in shares)	0
Weighted average exercise price
Outstanding at beginning of period (in dollars per share)	$ 24.20
Granted (in dollars per share)	0
Exercised (in dollars per share)	0
Forfeited (in dollars per share)	0
Outstanding at end of period (in dollars per share)	24.20
Options vested or expected to vest (in dollars per share)	24.20
Exercisable (in dollars per share)	$ 0
Weighted average remaining contractual term
Vested and expected to vest at end of period, weighted average remaining contractual life	8 years 8 months 4 days
Outstanding at end of period, weighted average remaining contractual life	8 years 8 months 4 days
Exercisable at end of period, weighted average remaining contractual life	0 years
Additional disclosures
Unrecognized compensation costs	$ 0.2
Period for recognition of unrecognized compensation cost	1 year 8 months 12 days

Restructuring and related cha_3

Restructuring and related charges (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Feb. 27, 2021	Feb. 27, 2021	Feb. 29, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring, Incurred cost	$ 1,300	$ 3,800
Restructuring and Related Cost, Cost Incurred to Date	9,300	9,300
Changes to the restructuring liability
Balance as of August 29, 2020		4,139
Charges		3,262
Cash payments		(6,290)
Non-cash settlements or adjustments		0
Balance as of February 27, 2021	1,111	1,111
Loss on operating lease right-of-use asset impairment	300	681	$ 0
(Gain) loss on Termination of Lease		(154)	$ 0
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring, Expected cost	10,000	10,000
Changes to the restructuring liability
Balance as of August 29, 2020		4,139
Charges		3,118
Cash payments		(6,146)
Non-cash settlements or adjustments		0
Balance as of February 27, 2021	1,111	1,111
Other Restructuring
Changes to the restructuring liability
Balance as of August 29, 2020		0
Charges		144
Cash payments		(144)
Non-cash settlements or adjustments		0
Balance as of February 27, 2021	$ 0	$ 0